Cargando…
Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients
PURPOSE OF REVIEW: Severe coronavirus disease 2019 (COVID-19) is characterized by the development of a deleterious hyperinflammatory response, in which the pleiotropic cytokine interleukin (IL)-6 plays a pivotal role. The administration of immunomodulatory therapies has been proposed to revert the t...
Autores principales: | Fernández-Ruiz, Mario, Aguado, José María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581948/ https://www.ncbi.nlm.nih.gov/pubmed/33110739 http://dx.doi.org/10.1007/s40472-020-00306-x |
Ejemplares similares
-
Antivirals for COVID-19 in Solid Organ Transplant Recipients
por: Laracy, Justin C., et al.
Publicado: (2020) -
General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients
por: Kim, Min Young, et al.
Publicado: (2020) -
SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses
por: Grupper, Ayelet, et al.
Publicado: (2022) -
Diagnostic Testing of COVID-19 in Solid Organ Transplantation: Current Clinical Application and Future Strategies
por: Trubin, Paul A., et al.
Publicado: (2020) -
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
por: Dhand, Abhay, et al.
Publicado: (2022)